Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

Cited In for PubMed (Select 15578694)

1.

Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.

Gustbée E, Tryggvadottir H, Markkula A, Simonsson M, Nodin B, Jirström K, Rose C, Ingvar C, Borgquist S, Jernström H.

BMC Clin Pathol. 2015 May 20;15:8. doi: 10.1186/s12907-015-0008-2. eCollection 2015.

2.

Effects of statins on the risk of hepatocellular carcinoma.

Mansourian PG, Yoneda M, Krishna Rao M, Martinez FJ, Thomas E, Schiff ER.

Gastroenterol Hepatol (N Y). 2014 Jul;10(7):417-26.

3.

Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies.

Pradelli D, Soranna D, Zambon A, Catapano A, Mancia G, La Vecchia C, Corrao G.

Cancer Med. 2015 May;4(5):770-80. doi: 10.1002/cam4.411. Epub 2015 Mar 21.

4.

Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink.

McGlynn KA, Hagberg K, Chen J, Graubard BI, London WT, Jick S, Sahasrabuddhe VV.

J Natl Cancer Inst. 2015 Feb 26;107(4). pii: djv009. doi: 10.1093/jnci/djv009. Print 2015 Apr.

PMID:
25722350
5.

Statin use and risk of liver cancer: an update meta-analysis.

Shi M, Zheng H, Nie B, Gong W, Cui X.

BMJ Open. 2014 Sep 16;4(9):e005399. doi: 10.1136/bmjopen-2014-005399.

6.

Statin use and risk of hepatocellular carcinoma in a U.S. population.

McGlynn KA, Divine GW, Sahasrabuddhe VV, Engel LS, VanSlooten A, Wells K, Yood MU, Alford SH.

Cancer Epidemiol. 2014 Oct;38(5):523-7. doi: 10.1016/j.canep.2014.06.009. Epub 2014 Aug 10.

PMID:
25113938
7.

Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer.

Litzenburger BC, Brown PH.

Curr Breast Cancer Rep. 2014;6:96-109. Review.

8.

Does Statin or ASA Affect Survival When Prostate Cancer Is Treated with External Beam Radiation Therapy?

Caon J, Paquette M, Hamm J, Pickles T.

Prostate Cancer. 2014;2014:184297. doi: 10.1155/2014/184297. Epub 2014 Mar 3.

9.

Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies.

Lytras T, Nikolopoulos G, Bonovas S.

World J Gastroenterol. 2014 Feb 21;20(7):1858-70. doi: 10.3748/wjg.v20.i7.1858. Review.

10.

Nutrition and metabolism in hepatocellular carcinoma.

Smith RJ.

Hepatobiliary Surg Nutr. 2013 Apr;2(2):89-96. doi: 10.3978/j.issn.2304-3881.2012.11.02. Review.

11.

Do statins reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis B?

Fung J, Lai CL, Yuen MF, Ng IO.

Hepatobiliary Surg Nutr. 2013 Feb;2(1):34-6. doi: 10.3978/j.issn.2304-3881.2012.10.04. No abstract available.

12.

Chemoprevention for hepatocellular carcinoma: the role of statins.

Cabibbo G, Petta S, Cammà C.

Hepatobiliary Surg Nutr. 2013 Feb;2(1):1-3. doi: 10.3978/j.issn.2304-3881.2012.09.01. No abstract available.

13.

Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis.

Yi X, Jia W, Jin Y, Zhen S.

PLoS One. 2014 Jan 31;9(1):e87019. doi: 10.1371/journal.pone.0087019. eCollection 2014.

14.

Can statins reduce risk of lung cancer, especially among elderly people? A meta-analysis.

Deng Z, Zhang S, Yi L, Chen S.

Chin J Cancer Res. 2013 Dec;25(6):679-88. doi: 10.3978/j.issn.1000-9604.2013.11.02.

15.

A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors.

Mira E, Carmona-Rodríguez L, Tardáguila M, Azcoitia I, González-Martín A, Almonacid L, Casas J, Fabriás G, Mañes S.

Oncotarget. 2013 Dec;4(12):2288-301.

16.

Statin use and risk of lung cancer: a meta-analysis of observational studies and randomized controlled trials.

Wang J, Li C, Tao H, Cheng Y, Han L, Li X, Hu Y.

PLoS One. 2013 Oct 25;8(10):e77950. doi: 10.1371/journal.pone.0077950. eCollection 2013.

17.

Detection of the Hematopoietic Stem and Progenitor Cell Marker CD133 during Angiogenesis in Three-Dimensional Collagen Gel Culture.

Akita M, Tanaka K, Matsumoto S, Komatsu K, Fujita K.

Stem Cells Int. 2013;2013:927403. doi: 10.1155/2013/927403. Epub 2013 Jun 23.

18.

Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age.

McDougall JA, Malone KE, Daling JR, Cushing-Haugen KL, Porter PL, Li CI.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1529-37. doi: 10.1158/1055-9965.EPI-13-0414. Epub 2013 Jul 5.

19.

Statins and the risk of lung cancer: a meta-analysis.

Tan M, Song X, Zhang G, Peng A, Li X, Li M, Liu Y, Wang C.

PLoS One. 2013;8(2):e57349. doi: 10.1371/journal.pone.0057349. Epub 2013 Feb 28.

20.

Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed diabetes.

Hsu CN, Chang CH, Lin YS, Lin JW, Caffrey JL.

PLoS One. 2013;8(2):e55625. doi: 10.1371/journal.pone.0055625. Epub 2013 Feb 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk